The disposition of oral amodiaquine in Papua New Guinean children with falciparum malaria.
about
Amodiaquine-associated adverse effects after inadvertent overdose and after a standard therapeutic dose.A high force of plasmodium vivax blood-stage infection drives the rapid acquisition of immunity in papua new guinean children.Development, evaluation, and application of an in silico model for antimalarial drug treatment and failure.Population pharmacokinetics of artesunate and amodiaquine in African childrenPrevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New GuineaWorld Antimalarial Resistance Network (WARN) IV: clinical pharmacology.Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy.Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers.CYP2C8 and antimalaria drug efficacy.Effect of concomitant artesunate administration and cytochrome P4502C8 polymorphisms on the pharmacokinetics of amodiaquine in Ghanaian children with uncomplicated malaria.Field-adapted sampling of whole blood to determine the levels of amodiaquine and its metabolite in children with uncomplicated malaria treated with amodiaquine plus artesunate combinationTolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers.Amodiaquine pharmacogenetics.The pharmacogenetics of antimalaria artemisinin combination therapy.Pharmacokinetic profile of artemisinin derivatives and companion drugs used in artemisinin-based combination therapies for the treatment of Plasmodium falciparum malaria in children.Pharmacokinetic determinants of the window of selection for antimalarial drug resistanceMoving about.Artesunate/Amodiaquine-Induced Acute Extrapyramidal Reactions in Children and Younger Adults: Case Series Assessment.
P2860
Q33605669-5DF8FF8D-B6BF-472B-BBBA-BD594C175378Q34990680-97483612-6C06-4630-878D-43E5CE5439B3Q35065737-DF002690-5B5A-4C19-9C07-7AFDA70BEB06Q35575394-14251172-6D14-4C31-AC0B-D7CA61CA3292Q35669950-FB116331-E976-4741-8740-B70605868CB8Q36054710-C29EF31F-F5E5-4768-9801-90DDA6759382Q36364248-D409A6AD-B9F1-413B-8CAF-51108AB0D97AQ36718308-9D56F837-5F60-4098-8C74-BDBD47442E67Q36730638-1CAAA826-44B2-4B62-9F39-106541AF4470Q36993430-121FE18A-7390-411E-875C-453DB22BE340Q37182220-0D1AC31F-1EDD-4952-9AAA-76E4EC7392FCQ37272811-2EEBDB7F-6BF3-4773-A135-2DAFE813F16EQ37293982-5D362AAE-5C8F-4C48-9F7C-6C5C0DDCF11AQ37928680-9AE98AC2-7E99-493E-B46E-39B53EBEFE2AQ38071558-404D7D48-DCEC-446A-BC51-89A1CE7BCD8BQ39489910-2C92E71B-A606-4850-9F47-7744CA1A1B96Q42758983-F46E6EC9-EC98-48EA-B661-032E0829ACF3Q47959465-72EC593E-2152-49AB-A5F5-0C325EC275D0
P2860
The disposition of oral amodiaquine in Papua New Guinean children with falciparum malaria.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The disposition of oral amodia ...... ldren with falciparum malaria.
@ast
The disposition of oral amodia ...... ldren with falciparum malaria.
@en
type
label
The disposition of oral amodia ...... ldren with falciparum malaria.
@ast
The disposition of oral amodia ...... ldren with falciparum malaria.
@en
prefLabel
The disposition of oral amodia ...... ldren with falciparum malaria.
@ast
The disposition of oral amodia ...... ldren with falciparum malaria.
@en
P2093
P2860
P921
P1476
The disposition of oral amodiaquine in Papua New Guinean children with falciparum malaria
@en
P2093
Hombhanje FW
Hwaihwanje I
Ishizaki T
Kobayakawa T
Nakagawa M
P2860
P304
P356
10.1111/J.1365-2125.2004.02257.X
P407
P577
2005-03-01T00:00:00Z